Table 2 Summary of Adverse Events

From: Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis

	Grade
	No. of patients (%)
	1	2	3	4
Fatigue	4 (33)	0	0	0
Malaise	1 (8)	0	0	0
Fever	2 (17)	0	0	0
Chills	1 (8)	0	0	0
Tachycardia	1 (8)	0	0	0
Headache	3 (25)	0	0	0
Anemia	2 (17)	0	0	0
Leukopenia	1 (8)	1 (8)	0	0
Neutropenia	0	1 (8)	0	0
Nausea	2 (17)	0	0	0
Constipation	1 (8)	0	0	0
Dysgeusia	1 (8)	0	0	0
Hyperthyroid	2 (17)	0	0	0
Hyperbilirubinemia	1 (8)	0	0	0
Increase in amlyase	1 (8)	0	0	0
Increase in lipase	2 (17)	0	0	0
Dry skin	0	1 (8)	0	0
Infusion reaction	0	1 (8)	0	0
Dry mouth	3 (25)	2 (17)	0	0
Maculopapular rash	1 (8)	0	0	0

Back to article page